![]() ![]() The rapid evolution of cloud-based solutions has helped address some IT infrastructure issues relating to data storage and retrieval, although challenges remain with respect to data security. Further advances in high-throughput technologies have led to a decline in sequencing costs and an increase in data generation. ![]() Genomics continues to attract significant investment from public and private funds, which has fueled the development of subdisciplines such as chemogenomics, metagenomics, pharmacogenomics and toxicogenomics. The use of different tools manufactured by key players is likely to propel the growth of the bioinformatics market during theforecast period. Sample preparation protocols, dataquality and disease status information are also required during sequencing. For example, publicly available datasets of human BCR were selected to represent different sequencing platforms such as Illumina MiSeq, Roche 454 and Ion Torrent. Moreover, the advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies and usage of different bioinformatic tools. The high growth rate of this segment is attributed to factors such as demand of antibodies research, the expanding COVID-19 pandemic, epidemics of other infectious diseases, and an increase in R&D activities by key companies to develop new data regarding genetic consequences to counter the rise in differentinfectious diseases globally. The genomics segment recorded $REDACTED billion in revenue in 2019, and it is estimated to grow at a compound annual growth rate (CAGR) of REDACTED% during the forecast period. Among application segments, the genomics segment accounted for the highest market share in the global market for bioinformatics in 2019. The global market for bioinformatics was valued at approximately $REDACTED billion in 2019. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |